AT332531B - Verfahren zur herstellung eines nierensteinlosenden praparates - Google Patents

Verfahren zur herstellung eines nierensteinlosenden praparates

Info

Publication number
AT332531B
AT332531B AT925372A AT925372A AT332531B AT 332531 B AT332531 B AT 332531B AT 925372 A AT925372 A AT 925372A AT 925372 A AT925372 A AT 925372A AT 332531 B AT332531 B AT 332531B
Authority
AT
Austria
Prior art keywords
manufacturing
less preparation
stone less
stone
preparation
Prior art date
Application number
AT925372A
Other languages
German (de)
English (en)
Other versions
ATA925372A (de
Inventor
Jozsef Dipl Ing Chem Nemes
Rudolf Dipl Ing Chem Szebeni
Mihaly Dipl Ing Chem Berenyi
Dezso Dr Med Frang
Miklos Dipl Ing Chem Marso
Gyula Dr Med Gal
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of ATA925372A publication Critical patent/ATA925372A/de
Application granted granted Critical
Publication of AT332531B publication Critical patent/AT332531B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT925372A 1971-11-08 1972-10-31 Verfahren zur herstellung eines nierensteinlosenden praparates AT332531B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI1185A HU165181B (el) 1971-11-08 1971-11-08

Publications (2)

Publication Number Publication Date
ATA925372A ATA925372A (de) 1976-01-15
AT332531B true AT332531B (de) 1976-10-11

Family

ID=10994422

Family Applications (1)

Application Number Title Priority Date Filing Date
AT925372A AT332531B (de) 1971-11-08 1972-10-31 Verfahren zur herstellung eines nierensteinlosenden praparates

Country Status (9)

Country Link
AT (1) AT332531B (el)
CA (1) CA978479A (el)
CS (1) CS217603B1 (el)
DD (1) DD100631A1 (el)
DE (1) DE2252665A1 (el)
GB (1) GB1403900A (el)
HU (1) HU165181B (el)
IL (1) IL40685A (el)
SU (1) SU1009467A1 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3046580A1 (de) * 1980-12-11 1982-07-01 Leskovar, Peter, Dr.-Ing., 8000 München Harnsteinaufloesende mittel
DE3728814A1 (de) * 1987-08-28 1989-03-30 Lentia Gmbh Loesung zur anwendung als spuelfluessigkeit in der zerstoerung von koerperfremden ablagerungen in menschlichen und tierischen geweben oder koerperhohlraeumen
JP2545479B2 (ja) * 1989-02-07 1996-10-16 ミッション ファーマカル カンパニー，インコーポレーテッド 医薬組成物
CA1326040C (en) * 1989-11-16 1994-01-11 Neill B. Walsdorf Magnesium-potassium citrate
DE4409949C2 (de) * 1994-03-23 1996-11-21 Madaus Ag Verwendung von Calcium-Alkalicitraten zur Prophylaxe und Behandlung degenerativer Erkrankungen des Knochengerüstes
DE10028167B4 (de) * 2000-06-09 2004-02-19 Storch, Rüdiger, Dr. Verwendung von Calciumsalzen zur Entgegenwirkung der Bildung von Oxalatharnsteinen
US8603989B2 (en) 2008-05-22 2013-12-10 Bristol-Myers Squibb Company Method for treating and preventing kidney stones employing an SGLT2 inhibitor and composition containing same
FR2967576B1 (fr) * 2010-11-18 2013-07-12 Advicenne Pharma Composition pharmaceutique comprenant du sel precurseur du cycle de krebs, en particulier du sel de citrate, et son utilisation comme medicament
FR2967578B1 (fr) 2010-11-18 2012-12-28 Advicenne Pharma Composition pharmaceutique comportant des sels de citrate et de bicarbonate, et son utilisation pour le traitement de la cystinurie
BR112015023495A8 (pt) * 2013-03-15 2019-12-03 Massachusetts Gen Hospital bebida compreendendo citrato, kit, e, concentrado de bebida

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328304A (en) * 1964-07-31 1967-06-27 Guardian Chemical Corp Chelating agents and methods for their manufacture
FR2019261A1 (en) * 1969-03-19 1970-07-03 Melon Jean Marie Treatment of oxalic lithiase with succinic - acid and its derivs

Also Published As

Publication number Publication date
DE2252665C2 (el) 1987-09-10
SU1009467A1 (ru) 1983-04-07
IL40685A0 (en) 1972-12-29
DE2252665A1 (de) 1973-05-10
CA978479A (en) 1975-11-25
GB1403900A (en) 1975-08-28
IL40685A (en) 1976-08-31
DD100631A1 (el) 1973-10-05
CS217603B1 (en) 1983-01-28
ATA925372A (de) 1976-01-15
HU165181B (el) 1974-07-27

Similar Documents

Publication Publication Date Title
AT347038B (de) Verfahren zur herstellung eines diaetpraeparats
AT321082B (de) Verfahren zur Herstellung eines Nahrungsmittels
AT323628B (de) Verfahren zur herstellung eines gepressten gegenstandes
AT316756B (de) Verfahren zur herstellung eines lactulosepulvers
CH553435A (de) Verfahren zur herstellung eines koronageneratordrahtes.
AT332531B (de) Verfahren zur herstellung eines nierensteinlosenden praparates
AT326354B (de) Verfahren zur herstellung eines pfropf-copolymeren
ATA885874A (de) Verfahren zur herstellung eines schwammartigen keramischen korpers
AT340680B (de) Verfahren zur herstellung eines pfropfcopolymers
AT329271B (de) Verfahren zur herstellung eines modifizierten aminoplasten
AT312805B (de) Verfahren zur Herstellung eines Sekretin-Präparates
AT332538B (de) Verfahren zur herstellung eines 7beta-aminocephalosporins
AT330962B (de) Verfahren zur herstellung eines praparates zur nasalen applikation
AT305496B (de) Verfahren zur Herstellung eines blutstillenden Präparats
CH533002A (de) Verfahren zur Herstellung eines Verbundelements
AT332539B (de) Verfahren zur herstellung eines immunisierungsmittels
AT314736B (de) Verfahren zur herstellung eines lactulosepulvers
AT329743B (de) Verfahren zur herstellung eines praparates zur nasalen applikation
AT316753B (de) Verfahren zur Herstellung eines Fibrinolyseaktivators
CH541862A (de) Verfahren zur Herstellung eines Kondensators
AT333027B (de) Verfahren zur herstellung eines harzes
AT328741B (de) Verfahren zur herstellung eines modifizierten aminoplasten
AT337454B (de) Verfahren zur herstellung eines latex
AT330942B (de) Verfahren zur herstellung eines vlieses
AT332643B (de) Verfahren zur herstellung eines harzes

Legal Events

Date Code Title Description
ELA Expired due to lapse of time